A functional role of CD133 in tumors is suggested by the evidence that in vitro targeting of CD133 with a specific binding peptide reduced colon and breast tumor cell motility [10] and in vivo down-regulation of CD133 severely impaired the capacity of melanoma cells to metastasize [11]. Here, PROM1 is linked to breast neoplasm.